question_id,date,category,question_text,baseline_success,baseline_actually_answered,baseline_has_expected,baseline_confidence,baseline_text,baseline_error,baseline_time,baseline_input_tokens,baseline_output_tokens,togomcp_success,togomcp_has_expected,togomcp_confidence,togomcp_text,togomcp_error,togomcp_time,togomcp_input_tokens,togomcp_output_tokens,togomcp_cache_creation_input_tokens,togomcp_cache_read_input_tokens,tools_used,tool_details,value_add,expected_answer,notes
13,2026-01-09,Precision,What is the molecular weight of PubChem compound CID2244?,True,False,False,0.0,"I don't know the molecular weight of PubChem compound CID 2244 with certainty from my training data. To get accurate information about this specific compound, you would need to look it up directly in the PubChem database at https://pubchem.ncbi.nlm.nih.gov/ by searching for CID 2244.",,3.780740976333618,53,81,True,True,1.0,"The molecular weight of PubChem compound CID 2244 is **180.16 g/mol**.

This compound is **2-acetyloxybenzoic acid** (also known as **aspirin** or acetylsalicylic acid), with the molecular formula C9H8O4.",,14.343309164047241,9,177,708,52646,mcp__togomcp__get_compound_attributes_from_pubchem,"[{""name"": ""mcp__togomcp__get_compound_attributes_from_pubchem"", ""input"": {""pubchem_compound_id"": ""2244""}}]",CRITICAL,180.16,Database: PubChem. CID2244 is aspirin. Tests retrieval of exact molecular properties. Baseline won't know specific PubChem CID properties. Verified via get_compound_attributes_from_pubchem in pubchem_exploration.md returning MW 180.16 Da.
14,2026-01-09,Precision,What is the ChEMBL ID for imatinib mesylate?,True,True,True,1.0,"The ChEMBL ID for imatinib mesylate is **CHEMBL1642**.

Imatinib mesylate is the mesylate (methanesulfonate) salt form of imatinib, a tyrosine kinase inhibitor used primarily in the treatment of chronic myeloid leukemia (CML) and gastrointestinal stromal tumors (GISTs). The free base imatinib itself has the ChEMBL ID CHEMBL941.",,4.028428792953491,55,116,True,True,1.0,"The ChEMBL ID for imatinib mesylate is **CHEMBL1642**.

Note that the parent compound imatinib (without the mesylate salt) has a different ChEMBL ID: CHEMBL941.",,14.246427059173584,9,166,607,52648,mcp__togomcp__search_chembl_molecule,"[{""name"": ""mcp__togomcp__search_chembl_molecule"", ""input"": {""query"": ""imatinib mesylate"", ""limit"": 5}}]",VALUABLE,CHEMBL1642,Database: ChEMBL. Tests drug compound identification. Imatinib mesylate is the salt form of imatinib (CHEMBL941). Baseline may know imatinib but not specific ChEMBL IDs. Verified via search_chembl_molecule in chembl_exploration.md.
15,2026-01-09,Completeness,How many protein structure entries in PDB used electron microscopy as the experimental method?,True,False,False,0.0,"I don't have access to real-time PDB (Protein Data Bank) statistics, but I can provide context based on my training data (up to April 2024).

As of my last update, electron microscopy (EM), particularly cryo-EM, had become increasingly prominent in structural biology. By early 2024, there were approximately **15,000-20,000+ structures** determined by electron microscopy in the PDB, and this number was growing rapidly.

To give you perspective on the trend:
- In 2020: ~2,500-3,000 EM structures deposited that year
- By 2023-2024: Annual deposits were exceeding 4,000-5,000 EM structures per year

Cryo-EM has experienced explosive growth due to technological advances (better detectors, improved software, resolution improvements), making it especially valuable for:
- Large macromolecular complexes
- Membrane proteins
- Structures difficult to crystallize

For the most current and exact number, you would need to query the PDB database directly at rcsb.org, where you can filter structures by experimental method to get real-time statistics.",,8.825398206710815,54,263,True,False,0.0,"Based on the search results from PDBj (Protein Data Bank Japan), there are **33,635 protein structure entries** in the PDB that used electron microscopy as the experimental method.

This includes various types of electron microscopy techniques such as:
- Cryo-electron microscopy (cryo-EM)
- Electron cryo-microscopy
- Electron cryomicroscopy

The search results show a diverse range of structures determined by EM, including ribosomal subunits, ion channels, viral proteins (including coronavirus spike proteins), membrane proteins, and various protein complexes. Electron microscopy, particularly cryo-EM, has become an increasingly important technique for determining protein structures, especially for large macromolecular complexes that are difficult to crystallize for X-ray crystallography.",,20.504691123962402,9,307,1194,52647,mcp__togomcp__search_pdb_entity,"[{""name"": ""mcp__togomcp__search_pdb_entity"", ""input"": {""db"": ""pdb"", ""query"": ""electron microscopy"", ""limit"": 20}}]",CRITICAL,"15,032",Database: PDB. Tests counting by experimental method. Requires aggregating exptl.method field. Baseline cannot access current PDB statistics. Verified via SPARQL GROUP BY query in pdb_exploration.md showing ~7.3% of total structures.
16,2026-01-09,Completeness,How many designated intractable diseases in NANDO have MONDO cross-references?,True,False,False,0.0,"I don't have access to real-time databases or the ability to query NANDO (Nanbyou Database - Japan's database of designated intractable diseases) directly. 

To answer this question accurately, you would need to:

1. Access the NANDO database (maintained by Japan's Ministry of Health, Labour and Welfare)
2. Query for all designated intractable diseases entries
3. Filter for those that have MONDO (Monarch Disease Ontology) cross-references
4. Count the results

From my training knowledge, I know that:
- NANDO contains information about Japan's designated intractable/rare diseases
- MONDO is a comprehensive disease ontology that integrates multiple disease resources
- Cross-referencing between databases is common practice in bioinformatics

However, I cannot provide you with the specific current number without access to the actual database. The number would also change over time as both databases are regularly updated with new mappings and entries.

If you need this information, I'd recommend checking the NANDO database directly or looking at recent publications about NANDO-MONDO mappings.",,8.108879089355469,55,245,True,False,0.0,"## Answer

**1,946** designated intractable diseases in NANDO have MONDO cross-references.

To provide context:
- Total designated intractable diseases in NANDO (those with notification numbers): **2,454**
- Designated diseases with MONDO mappings: **1,946**
- **Coverage: ~79.3%** of designated intractable diseases have MONDO cross-references

This high coverage rate indicates excellent integration between the Japanese NANDO ontology and the international MONDO Disease Ontology, facilitating cross-reference between Japanese government-designated rare diseases and globally standardized disease classifications.",,32.02720594406128,26,903,11430,153892,"mcp__togomcp__get_sparql_example, mcp__togomcp__get_sparql_example, mcp__togomcp__get_MIE_file, mcp__togomcp__run_sparql, mcp__togomcp__run_sparql","[{""name"": ""mcp__togomcp__get_sparql_example"", ""input"": {""dbname"": ""nando""}}, {""name"": ""mcp__togomcp__get_sparql_example"", ""input"": {""dbname"": ""mondo""}}, {""name"": ""mcp__togomcp__get_MIE_file"", ""input"": {""dbname"": ""nando""}}, {""name"": ""mcp__togomcp__run_sparql"", ""input"": {""dbname"": ""nando"", ""sparql_query"": ""PREFIX owl: <http://www.w3.org/2002/07/owl#>\nPREFIX skos: <http://www.w3.org/2004/02/skos/core#>\nPREFIX nando: <http://nanbyodata.jp/ontology/NANDO_>\n\nSELECT (COUNT(DISTINCT ?disease) as ?count)\nFROM <http://nanbyodata.jp/ontology/nando>\nWHERE {\n  ?disease a owl:Class ;\n           nando:hasNotificationNumber ?notif_num ;\n           skos:closeMatch ?mondo .\n  FILTER(STRSTARTS(STR(?mondo), \""http://purl.obolibrary.org/obo/MONDO_\""))\n}""}}, {""name"": ""mcp__togomcp__run_sparql"", ""input"": {""dbname"": ""nando"", ""sparql_query"": ""PREFIX owl: <http://www.w3.org/2002/07/owl#>\nPREFIX nando: <http://nanbyodata.jp/ontology/NANDO_>\n\nSELECT (COUNT(DISTINCT ?disease) as ?total_designated)\nFROM <http://nanbyodata.jp/ontology/nando>\nWHERE {\n  ?disease a owl:Class ;\n           nando:hasNotificationNumber ?notif_num .\n}""}}]",CRITICAL,"2,341","Database: NANDO, MONDO. Tests cross-database mapping coverage. NANDO has 2,777 total diseases with 84% MONDO coverage. Baseline cannot compute this statistic. Verified in nando_exploration.md via skos:closeMatch counting."
17,2026-01-09,Integration,Convert PubChem CID2244 to its ChEBI identifier.,True,False,False,0.0,"I don't know the ChEBI identifier for PubChem CID 2244 with certainty from my training data alone. 

To accurately convert between PubChem CID and ChEBI identifiers, you would typically need to:
1. Look up CID 2244 in the PubChem database to identify the compound
2. Use cross-reference databases or tools like UniChem, PubChem's own cross-references, or the ChEBI database search function to find the corresponding ChEBI ID

If you let me know what compound CID 2244 represents, I might be able to help identify its ChEBI ID, or you could query the PubChem or ChEBI databases directly for this cross-reference information.",,6.020268678665161,54,171,True,True,1.0,"The PubChem CID 2244 converts to **ChEBI:15365**.

This compound is aspirin (acetylsalicylic acid), a commonly used pain reliever and anti-inflammatory medication.",,12.6965491771698,8,169,471,52647,mcp__togomcp__togoid_convertId,"[{""name"": ""mcp__togomcp__togoid_convertId"", ""input"": {""ids"": ""2244"", ""route"": ""pubchem_compound,chebi""}}]",CRITICAL,CHEBI:15365,"Database: PubChem, ChEBI. Tests chemical entity ID conversion. CID2244 is aspirin. Requires cross-database lookup or TogoID conversion. Baseline has limited chemical database cross-references. Verified path exists via rdf:type in pubchem_exploration.md."
18,2026-01-09,Integration,What is the UniProt ID for the human BRCA1 protein?,True,True,True,1.0,"The UniProt ID for the human BRCA1 protein is **P38398**.

BRCA1 (Breast Cancer Type 1 Susceptibility Protein) is a tumor suppressor protein that plays a critical role in DNA repair, cell cycle regulation, and genomic stability. Mutations in the BRCA1 gene are associated with increased risk of breast and ovarian cancers.",,3.9940390586853027,54,90,True,True,1.0,"The UniProt ID for the human BRCA1 protein is **P38398**.

This entry corresponds to the ""Breast cancer type 1 susceptibility protein"" in *Homo sapiens* (Human). BRCA1 functions as a RING-type E3 ubiquitin transferase (EC 2.3.2.27) and is also known as RING finger protein 53.",,13.873990058898926,9,201,795,52647,mcp__togomcp__search_uniprot_entity,"[{""name"": ""mcp__togomcp__search_uniprot_entity"", ""input"": {""query"": ""BRCA1 human"", ""limit"": 5}}]",VALUABLE,P38398,"Database: UniProt. Tests gene-to-protein ID lookup for well-known cancer gene. While baseline knows BRCA1, it cannot provide specific UniProt accessions. Verified via search_uniprot_entity in uniprot_exploration.md showing P38398 is human BRCA1 E3 ubiquitin ligase."
19,2026-01-09,Currency,How many structures related to mTOR signaling are currently in Reactome?,True,False,True,0.5,"I don't have access to current, real-time data from the Reactome database, so I cannot tell you the exact number of structures related to mTOR signaling that are currently in Reactome.

To get this information, you would need to:

1. Visit the Reactome website (reactome.org)
2. Use their search function to query ""mTOR signaling"" or ""mTOR pathway""
3. Browse the pathway browser to see the specific structures, protein complexes, and molecular entities involved in mTOR signaling pathways

The mTOR signaling pathway in Reactome typically includes various protein complexes (like mTORC1 and mTORC2), regulatory proteins, substrates, and associated signaling molecules, but the exact count would depend on the current version of the database and how Reactome categorizes and counts these entities.

If you need this specific information, I recommend checking the Reactome database directly or contacting their support team.",,6.6221959590911865,54,219,True,True,0.5,"Based on the search results from Reactome, there are **many structures related to mTOR signaling** currently in the database. From the query that returned 100 results (out of a larger total), I can provide you with a breakdown:

## Summary of mTOR-related structures in Reactome:

**Pathways:** 28 entries across multiple species including:
- ""MTOR signalling"" pathway (14 species variants)
- ""Energy dependent regulation of mTOR by LKB1-AMPK"" (14 species variants)

**Protein Complexes:** 60+ entries including:
- mTORC1 and mTORC2 complexes
- Various phosphorylated and activated forms
- Ragulator-associated complexes
- RHEB-bound complexes
- Species-specific variants

**Proteins:** 100+ entries including:
- MTOR protein across different species
- RPTOR (regulatory-associated protein of mTOR)
- Related signaling proteins (SOCS, RGS families)

**Reactions:** 50+ biochemical reactions involving mTOR signaling

**Other entities:** Interactors, drugs, and genes related to mTOR

The search returned 100 results but was clearly truncated. The actual total number is likely **several hundred entries** when considering:
- Multiple species orthologs (human, mouse, rat, zebrafish, fly, worm, yeast, etc.)
- Different complex formations and post-translational modifications
- Associated signaling pathways and regulatory mechanisms

Would you like me to search for more specific aspects of mTOR signaling, such as just human entries or specific complex types?",,23.205267906188965,9,485,16255,52647,mcp__togomcp__search_reactome_entity,"[{""name"": ""mcp__togomcp__search_reactome_entity"", ""input"": {""query"": ""mTOR signaling"", ""rows"": 100}}]",CRITICAL,10+ pathway instances,Database: Reactome. Tests access to current pathway data. mTOR signaling is actively studied with organism-specific pathway instances. Baseline from Jan 2025 won't reflect latest updates. Verified via bif:contains search in reactome_exploration.md.
20,2026-01-09,Currency,What is the most recent collection year for bacterial isolates in the AMR Portal?,True,False,False,0.0,"I don't have access to real-time data from the AMR (Antimicrobial Resistance) Portal or knowledge of its most recent updates. The collection year for bacterial isolates in the AMR Portal would depend on when the database was last updated and which surveillance systems or studies have submitted their most recent data.

To find the most recent collection year for bacterial isolates in the AMR Portal, I recommend:

1. Visiting the AMR Portal website directly
2. Checking their data documentation or metadata sections
3. Looking at their ""About"" or ""Data Sources"" pages
4. Reviewing any data release notes or update logs

These resources would provide you with the most accurate and current information about the temporal coverage of their database.",,5.55101203918457,54,160,True,True,1.0,"Perfect! The most recent collection year for bacterial isolates in the AMR Portal is **2025**.

According to the database metadata, the temporal coverage spans from 1911 to 2025, with 92 distinct collection years. The presence of 2025 data indicates that the AMR Portal includes very recent bacterial isolate samples from this year.",,38.172425985336304,27,814,11755,143990,"mcp__togomcp__run_sparql, mcp__togomcp__run_sparql, mcp__togomcp__get_MIE_file, mcp__togomcp__run_sparql","[{""name"": ""mcp__togomcp__run_sparql"", ""input"": {""dbname"": ""amrportal"", ""sparql_query"": ""\nPREFIX rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>\nPREFIX rdfs: <http://www.w3.org/2000/01/rdf-schema#>\nPREFIX amr: <http://purl.jp/bio/10/amr/>\nPREFIX xsd: <http://www.w3.org/2001/XMLSchema#>\n\nSELECT DISTINCT ?year\nWHERE {\n  ?isolate amr:collectionYear ?year .\n}\nORDER BY DESC(?year)\nLIMIT 1\n""}}, {""name"": ""mcp__togomcp__run_sparql"", ""input"": {""dbname"": ""amrportal"", ""sparql_query"": ""\nSELECT DISTINCT ?year\nWHERE {\n  ?isolate a ?type ;\n           ?collectionProp ?year .\n  FILTER(CONTAINS(STR(?collectionProp), \""collection\"") || CONTAINS(STR(?collectionProp), \""year\""))\n  FILTER(isNumeric(?year) || datatype(?year) = <http://www.w3.org/2001/XMLSchema#gYear>)\n}\nORDER BY DESC(?year)\nLIMIT 10\n""}}, {""name"": ""mcp__togomcp__get_MIE_file"", ""input"": {""dbname"": ""amrportal""}}, {""name"": ""mcp__togomcp__run_sparql"", ""input"": {""dbname"": ""amrportal"", ""sparql_query"": ""\nPREFIX amr: <http://example.org/ebiamr#>\n\nSELECT DISTINCT ?year\nFROM <http://rdfportal.org/dataset/amrportal>\nWHERE {\n  ?s a amr:PhenotypeMeasurement .\n  ?s amr:collectionYear ?year .\n}\nORDER BY DESC(?year)\nLIMIT 1\n""}}]",CRITICAL,2025,Database: AMR Portal. Tests access to current surveillance data. Collection years range 1911-2025 with continuous updates. Baseline cannot access current AMR surveillance data. Verified in amrportal_exploration.md showing temporal span to 2025.
21,2026-01-09,Specificity,What is the MeSH descriptor ID for Erdheim-Chester disease?,True,False,False,0.0,"I don't know the specific MeSH descriptor ID for Erdheim-Chester disease with certainty. 

While I know that Erdheim-Chester disease is a rare form of non-Langerhans cell histiocytosis, I cannot provide you with its exact MeSH (Medical Subject Headings) descriptor ID from my training knowledge alone. MeSH descriptor IDs are specific alphanumeric codes assigned by the National Library of Medicine, and without access to the current MeSH database, I cannot guarantee the accuracy of any ID I might recall.

To find this information accurately, you would need to search the official MeSH database at the National Library of Medicine's website.",,4.7309370040893555,53,151,True,False,0.0,"Based on my search, the MeSH identifier for Erdheim-Chester disease is **T459455** (which corresponds to the URI http://id.nlm.nih.gov/mesh/T459455).

This is a Supplementary Concept Record (SCR) in MeSH, not a main descriptor. The ""T"" prefix indicates it's a supplementary concept that is mapped to main MeSH descriptors for indexing purposes.",,31.72713589668274,21,681,1023,106231,"mcp__togomcp__search_mesh_entity, mcp__togomcp__run_sparql, mcp__togomcp__run_sparql","[{""name"": ""mcp__togomcp__search_mesh_entity"", ""input"": {""query"": ""Erdheim-Chester disease"", ""limit"": 10}}, {""name"": ""mcp__togomcp__run_sparql"", ""input"": {""dbname"": ""mesh"", ""sparql_query"": ""PREFIX meshv: <http://id.nlm.nih.gov/mesh/vocab#>\nPREFIX rdfs: <http://www.w3.org/2000/01/rdf-schema#>\n\nSELECT ?descriptor ?descriptorUI ?label\nWHERE {\n  ?descriptor a meshv:Descriptor ;\n              rdfs:label ?label ;\n              meshv:identifier ?descriptorUI .\n  FILTER(CONTAINS(LCASE(?label), \""erdheim-chester\""))\n}""}}, {""name"": ""mcp__togomcp__run_sparql"", ""input"": {""dbname"": ""mesh"", ""sparql_query"": ""PREFIX meshv: <http://id.nlm.nih.gov/mesh/vocab#>\nPREFIX rdfs: <http://www.w3.org/2000/01/rdf-schema#>\n\nSELECT ?label ?id\nWHERE {\n  <http://id.nlm.nih.gov/mesh/T459455> rdfs:label ?label .\n  OPTIONAL { <http://id.nlm.nih.gov/mesh/T459455> meshv:identifier ?id }\n}""}}]",CRITICAL,D031249,Database: MeSH. Tests retrieval of rare disease terminology. Erdheim-Chester is a rare histiocytic disorder. Baseline unlikely to know specific MeSH IDs for rare conditions. Verified via search_mesh_entity in mesh_exploration.md.
22,2026-01-09,Specificity,How many bacterial strains in BacDive can grow at temperatures above 70°C?,True,False,True,0.6666666666666666,"I don't have access to real-time data from the BacDive database, so I cannot provide you with the current exact number of bacterial strains that can grow at temperatures above 70°C.

However, I can tell you that:

1. **BacDive (Bacterial Diversity Metadatabase)** is a comprehensive database containing information about bacterial and archaeal strains, including their growth conditions.

2. **Bacteria that grow above 70°C** are classified as:
   - **Thermophiles** (optimal growth 50-80°C)
   - **Hyperthermophiles** (optimal growth above 80°C)

3. To find this information, you would need to:
   - Access BacDive directly at https://bacdive.dsmz.de/
   - Use their search/filter functions to query for strains with maximum or optimal growth temperatures above 70°C

The number of such strains in BacDive would depend on when the database was last updated and how many thermophilic/hyperthermophilic strains have been characterized and deposited in the database. This number changes as new strains are added to the database.

If you need the current count, I recommend querying the BacDive database directly using their web interface or API.",,8.680078744888306,57,296,True,True,0.6666666666666666,"Based on my query of the BacDive database, **296 bacterial strains** can grow at temperatures above 70°C.

These are hyperthermophilic organisms, with some impressive examples from the top results:

**Highest temperature tolerance:**
- **Pyrococcus kukulkanii** - can grow up to **112°C** (with a range of 70-112°C)
- **Pyrolobus fumarii** - grows at **103°C**
- **Aeropyrum pernix** - grows at up to **102°C**
- **Methanopyrus kandleri** - grows at **100°C**

These organisms are predominantly **archaea** (genera like *Pyrococcus*, *Pyrolobus*, *Ignicoccus*, *Methanopyrus*, *Aeropyrum*) that thrive in extreme environments such as deep-sea hydrothermal vents and volcanic hot springs. The ability to grow at such high temperatures requires special adaptations in their proteins, membranes, and cellular machinery to maintain stability and function under conditions that would denature most biological molecules.",,45.11225199699402,26,1166,10616,149331,"mcp__togomcp__run_sparql, mcp__togomcp__get_MIE_file, mcp__togomcp__run_sparql, mcp__togomcp__run_sparql","[{""name"": ""mcp__togomcp__run_sparql"", ""input"": {""dbname"": ""bacdive"", ""sparql_query"": ""\nPREFIX rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>\nPREFIX rdfs: <http://www.w3.org/2000/01/rdf-schema#>\nPREFIX bacdive: <http://bacdive.dsmz.de/rdfs/>\n\nSELECT (COUNT(DISTINCT ?strain) AS ?count)\nWHERE {\n  ?strain rdf:type bacdive:Strain .\n  ?strain bacdive:hasTemperatureRange ?tempRange .\n  ?tempRange bacdive:temperatureMaximum ?maxTemp .\n  FILTER(?maxTemp > 70)\n}\n""}}, {""name"": ""mcp__togomcp__get_MIE_file"", ""input"": {""dbname"": ""bacdive""}}, {""name"": ""mcp__togomcp__run_sparql"", ""input"": {""dbname"": ""bacdive"", ""sparql_query"": ""\nPREFIX schema: <https://purl.dsmz.de/schema/>\n\nSELECT (COUNT(DISTINCT ?strain) AS ?count)\nFROM <http://rdfportal.org/dataset/bacdive>\nWHERE {\n  ?strain a schema:Strain .\n  ?temp a schema:CultureTemperature ;\n        schema:describesStrain ?strain ;\n        schema:hasTemperatureRangeEnd ?tempEnd .\n  FILTER(?tempEnd > 70)\n}\n""}}, {""name"": ""mcp__togomcp__run_sparql"", ""input"": {""dbname"": ""bacdive"", ""sparql_query"": ""\nPREFIX schema: <https://purl.dsmz.de/schema/>\n\nSELECT ?strain ?label ?genus ?species ?tempStart ?tempEnd\nFROM <http://rdfportal.org/dataset/bacdive>\nWHERE {\n  ?strain a schema:Strain ;\n          rdfs:label ?label ;\n          schema:hasGenus ?genus ;\n          schema:hasSpecies ?species .\n  ?temp a schema:CultureTemperature ;\n        schema:describesStrain ?strain ;\n        schema:hasTemperatureRangeStart ?tempStart ;\n        schema:hasTemperatureRangeEnd ?tempEnd .\n  FILTER(?tempEnd > 70)\n}\nORDER BY DESC(?tempEnd)\nLIMIT 20\n""}}]",CRITICAL,Multiple thermophilic strains,Database: BacDive. Tests niche microbiology data retrieval. Thermophiles are specialized organisms. Baseline has no access to BacDive strain-specific growth conditions. Verified as documented finding in bacdive_exploration.md.
23,2026-01-09,Structured Query,Find all FDA-approved drugs in PubChem with molecular weight between 150 and 200 Da.,True,False,False,0.25,"I appreciate your question, but I need to be honest about my limitations here.

To find FDA-approved drugs in PubChem with specific molecular weight constraints (150-200 Da), you would need to:

1. **Access PubChem directly** - Query their database using their search tools or API
2. **Apply filters** for:
   - FDA approval status
   - Molecular weight range (150-200 Da)

However, I cannot access PubChem or any external databases in real-time. I only have training knowledge up to my knowledge cutoff date.

**What I can tell you:**

Some examples of FDA-approved drugs that fall roughly in this molecular weight range include:
- **Aspirin** (~180 Da)
- **Ibuprofen** (~206 Da - slightly above your range)
- **Acetaminophen/Paracetamol** (~151 Da)
- **Caffeine** (~194 Da)

But I cannot provide you with a complete, current list of ALL such drugs from PubChem.

**To get the accurate answer you need:**
- Visit PubChem (pubchem.ncbi.nlm.nih.gov)
- Use their Advanced Search with molecular weight filters
- Apply the ""FDA Approved Drug"" annotation filter
- Or use PubChem's PUG REST API for programmatic access

I cannot perform this search for you without database access.",,9.096782207489014,61,327,True,True,0.75,"Excellent! I found FDA-approved drugs with molecular weights between 150 and 200 Da. Let me provide you with a comprehensive summary of the results.

## FDA-Approved Drugs in PubChem with Molecular Weight 150-200 Da

I found **200+ FDA-approved drugs** in this molecular weight range. Here's a summary with some notable examples:

### Examples of FDA-Approved Drugs Found:

1. **Tartaric acid (CID875)** - MW: 150.09 Da
   - Formula: C₄H₆O₆
   - IUPAC: 2,3-dihydroxybutanedioic acid

2. **Paracetamol/Acetaminophen (CID1983)** - MW: 151.16 Da
   - Formula: C₈H₉NO₂
   - IUPAC: N-(4-hydroxyphenyl)acetamide
   - Common pain reliever and fever reducer

3. **Mandelic acid (CID1292)** - MW: 152.15 Da
   - Formula: C₈H₈O₃
   - IUPAC: 2-hydroxy-2-phenylacetic acid

4. **Vanillin (CID1183)** - MW: 152.15 Da
   - Formula: C₈H₈O₃
   - IUPAC: 4-hydroxy-3-methoxybenzaldehyde

5. **Dopamine (CID681)** - MW: 153.18 Da
   - Formula: C₈H₁₁NO₂
   - IUPAC: 4-(2-aminoethyl)benzene-1,2-diol
   - Important neurotransmitter used in treatment

### Distribution Summary:
- **150-155 Da**: ~100 compounds
- **155-160 Da**: ~70 compounds  
- **160-165 Da**: ~30+ additional compounds
- Total identified: 200+ FDA-approved drugs (query limited to 200 results)

The query successfully identified a diverse range of FDA-approved pharmaceutical compounds including analgesics, neurotransmitters, organic acids, and various other therapeutic agents within the specified molecular weight range.",,42.37321591377258,28,1568,20123,167463,"mcp__togomcp__get_MIE_file, mcp__togomcp__run_sparql, mcp__togomcp__run_sparql, mcp__togomcp__get_compound_attributes_from_pubchem, mcp__togomcp__get_compound_attributes_from_pubchem, mcp__togomcp__get_compound_attributes_from_pubchem, mcp__togomcp__get_compound_attributes_from_pubchem, mcp__togomcp__get_compound_attributes_from_pubchem","[{""name"": ""mcp__togomcp__get_MIE_file"", ""input"": {""dbname"": ""pubchem""}}, {""name"": ""mcp__togomcp__run_sparql"", ""input"": {""dbname"": ""pubchem"", ""sparql_query"": ""PREFIX vocab: <http://rdf.ncbi.nlm.nih.gov/pubchem/vocabulary#>\nPREFIX obo: <http://purl.obolibrary.org/obo/>\nPREFIX sio: <http://semanticscience.org/resource/>\n\nSELECT ?compound ?weight\nWHERE {\n  ?compound a vocab:Compound ;\n            obo:RO_0000087 vocab:FDAApprovedDrugs ;\n            sio:SIO_000008 ?weightDesc .\n  ?weightDesc a sio:CHEMINF_000334 ;\n              sio:SIO_000300 ?weight .\n  FILTER(?weight >= 150 && ?weight <= 200)\n}\nORDER BY ?weight\nLIMIT 100""}}, {""name"": ""mcp__togomcp__run_sparql"", ""input"": {""dbname"": ""pubchem"", ""sparql_query"": ""PREFIX vocab: <http://rdf.ncbi.nlm.nih.gov/pubchem/vocabulary#>\nPREFIX obo: <http://purl.obolibrary.org/obo/>\nPREFIX sio: <http://semanticscience.org/resource/>\n\nSELECT ?compound ?weight\nWHERE {\n  ?compound a vocab:Compound ;\n            obo:RO_0000087 vocab:FDAApprovedDrugs ;\n            sio:SIO_000008 ?weightDesc .\n  ?weightDesc a sio:CHEMINF_000334 ;\n              sio:SIO_000300 ?weight .\n  FILTER(?weight >= 150 && ?weight <= 200)\n}\nORDER BY ?weight\nLIMIT 200""}}, {""name"": ""mcp__togomcp__get_compound_attributes_from_pubchem"", ""input"": {""pubchem_compound_id"": ""875""}}, {""name"": ""mcp__togomcp__get_compound_attributes_from_pubchem"", ""input"": {""pubchem_compound_id"": ""681""}}, {""name"": ""mcp__togomcp__get_compound_attributes_from_pubchem"", ""input"": {""pubchem_compound_id"": ""1983""}}, {""name"": ""mcp__togomcp__get_compound_attributes_from_pubchem"", ""input"": {""pubchem_compound_id"": ""1292""}}, {""name"": ""mcp__togomcp__get_compound_attributes_from_pubchem"", ""input"": {""pubchem_compound_id"": ""1183""}}]",CRITICAL,20+ compounds including specific CIDs,"Database: PubChem. Tests multi-criteria filtering: (1) role = FDA-approved drug, (2) weight range 150-200. Requires structured query with numeric filtering. Baseline cannot execute this query. Verified in pubchem_exploration.md with SPARQL returning compounds like CID440545."
24,2026-01-09,Structured Query,Count resistance phenotypes by antibiotic for Pseudomonas aeruginosa in the AMR Portal.,True,False,True,0.5,"I don't have access to real-time databases or the ability to query the AMR (Antimicrobial Resistance) Portal directly. The AMR Portal is a dynamic database that contains current surveillance data on antimicrobial resistance patterns.

To count resistance phenotypes by antibiotic for *Pseudomonas aeruginosa* in the AMR Portal, you would need to:

1. **Visit the AMR Portal** (typically at https://www.who.int/antimicrobial-resistance/interagency-coordination-group/amr-portal/ or a similar national portal)

2. **Filter the data** by:
   - Organism: *Pseudomonas aeruginosa*
   - View resistance patterns by individual antibiotics

3. **Look for resistance phenotypes** such as:
   - Susceptible (S)
   - Intermediate (I)
   - Resistant (R)

Common antibiotics tested for *P. aeruginosa* typically include:
- Piperacillin-tazobactam
- Ceftazidime
- Cefepime
- Meropenem
- Imipenem
- Ciprofloxacin
- Levofloxacin
- Amikacin
- Gentamicin
- Colistin

The actual counts would depend on the specific dataset, time period, and geographic region you're interested in. If you need this specific data, I recommend accessing the AMR Portal directly or contacting the relevant public health authority that maintains the database.",,8.416011095046997,61,356,True,True,0.5,"Perfect! I've successfully retrieved the resistance phenotype counts by antibiotic for *Pseudomonas aeruginosa* from the AMR Portal. Here's a summary of the key findings:

## Resistance Phenotypes by Antibiotic for *Pseudomonas aeruginosa*

The database contains **13,577 total resistance measurements** for *P. aeruginosa* across **72 different antibiotics**. Here are the antibiotics with the highest number of resistance observations:

### Top Antibiotics by Resistance Count:

1. **Ciprofloxacin**: 813 resistant, 451 susceptible, 107 intermediate
2. **Meropenem**: 741 resistant, 518 susceptible, 162 intermediate
3. **Ceftazidime**: 604 resistant, 677 susceptible, 188 intermediate
4. **Levofloxacin**: 542 resistant, 420 susceptible, 55 intermediate
5. **Tobramycin**: 533 resistant, 665 susceptible, 23 intermediate
6. **Imipenem**: 420 resistant, 254 susceptible, 70 intermediate
7. **Gentamicin**: 382 resistant, 336 susceptible, 25 intermediate
8. **Cefepime**: 254 resistant, 291 susceptible, 93 intermediate
9. **Piperacillin-tazobactam**: 224 resistant, 231 susceptible, 115 intermediate
10. **Ceftazidime-avibactam**: 221 resistant, 238 susceptible, 1 intermediate

### Key Observations:

- **Fluoroquinolones** (ciprofloxacin, levofloxacin) show the highest resistance counts
- **Carbapenems** (meropenem, imipenem) show significant resistance, concerning for clinical treatment
- **Aminoglycosides** (tobramycin, gentamicin, amikacin) have substantial resistance
- **Newer agents** like ceftazidime-avibactam and ceftolozane-tazobactam still show resistance
- **Colistin** remains relatively effective (677 susceptible vs 12 resistant)

The data includes phenotypes: resistant, susceptible, intermediate, and occasionally ""susceptible-dose dependent.""",,33.07928109169006,15,940,13387,89775,"mcp__togomcp__get_MIE_file, mcp__togomcp__run_sparql","[{""name"": ""mcp__togomcp__get_MIE_file"", ""input"": {""dbname"": ""amrportal""}}, {""name"": ""mcp__togomcp__run_sparql"", ""input"": {""dbname"": ""amrportal"", ""sparql_query"": ""PREFIX amr: <http://example.org/ebiamr#>\n\nSELECT ?antibiotic ?phenotype (COUNT(*) as ?count)\nFROM <http://rdfportal.org/dataset/amrportal>\nWHERE {\n  ?s a amr:PhenotypeMeasurement .\n  ?s amr:organism \""Pseudomonas aeruginosa\"" .\n  ?s amr:antibioticName ?antibiotic .\n  ?s amr:resistancePhenotype ?phenotype .\n}\nGROUP BY ?antibiotic ?phenotype\nORDER BY ?antibiotic ?phenotype""}}]",CRITICAL,"Ciprofloxacin (813), meropenem (741), ceftazidime (604)",Database: AMR Portal. Tests organism-specific resistance aggregation. Requires filtering by organism and grouping by antibiotic. Baseline cannot access AMR surveillance data. Verified via SPARQL GROUP BY query in amrportal_exploration.md.
